Harding Loevner’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Harding Loevner's NBIX Position: Q3 2026 in Review
Harding Loevner opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 180,954 shares worth $25.8M. The stake represents 0.28% of the portfolio and ranks #49 among its holdings. This is a return to the name: Harding Loevner previously reported a position in NBIX as recently as Q3 2022.
Harding Loevner first reported a position in NBIX in Q1 2020 and has held it in 12 quarters since. 766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Harding Loevner held 180,954 shares of Neurocrine Biosciences worth $25.8M as of Q3 2026.
- Neurocrine Biosciences was a new Harding Loevner position in Q3 2026.
- Neurocrine Biosciences made up 0.28% of Harding Loevner's portfolio in Q3 2026, its #49 holding.
- Harding Loevner first reported a position in Neurocrine Biosciences in Q1 2020 and has held it in 12 quarters since.
- 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Harding Loevner's 13F filing for Q3 2026, filed 16 Nov 2026.